Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg in Multiple System Atrophy
NCT00750867Phase 2Completed
- Sponsor
- University of Massachusetts
- Start
- Jun 2008
- Primary completion
- Sep 2009
- Countries
- 1
01
Overview
Phase 2, open-label trial of intravenous immunoglobulin G in multiple system atrophy (MSA), sponsored by University of Massachusetts. Primary endpoint: Number of Adverse Events at 8 months. Started Jun 2008; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT00750867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750867.